Clinicopathologic, Immunophenotypic, and Molecular Cytogenetic Fluorescence In Situ Hybridization Analysis of Primary and Secondary Cutaneous Follicular Lymphomas

Although primary cutaneous follicular lymphoma (FL) is considered a distinct variant of FL in the World Health Organization classification (“cutaneous follicle center lymphoma”), its biologic relationship to nodal FL remains controversial. The clinical, morphologic, immunophenotypic, and molecular cytogenetic features of 17 patients with primary cutaneous FL were studied and compared with 16 patients with secondary cutaneous FL. The head and neck region was the most frequent site at initial skin presentation in both the primary and secondary cases. Among the primary cases, 29% of the 31 biopsies were grade 1, 48% grade 2, 13% grade 3, and 10% grade 3 with diffuse large B-cell (DLBCL) areas. Among the secondary cases, 38% of the 29 skin biopsies were grade 1, 45% grade 2, 3% grade 3, and 7% grade 3 with DLBCL areas with two not evaluable. A floral-like pattern was observed in 32% of primary FL but only 5% of secondary cases. Histologic progression was found in 21% of patients. CD10 expression was demonstrated in 90% (27 of 30) of primary cases and 96% (22 of 23) of secondary cases. Bcl-6 was expressed in all cases tested. Bcl-2 expression was detected in 57% (17 of 30) of the primary cases (100% of grade 1, 43% of grade 2, 40% of grade 3), whereas all secondary cases were bcl-2 positive (P = 0.0002). The t(14;18) translocation was identified by interphase fluorescence in situ hybridization (FISH) in biopsies from 31% (4 of 13) of the patients with primary FL compared with 77% (10 of 13) of those with secondary lymphoma (P < 0.05). Seven of the 17 (41%) patients with primary disease had cutaneous relapse, including 1 who also developed nodal disease. Bcl-2 positivity was seen in 4 of these 7 patients. Eight of the 16 (50%) patients with secondary FL had cutaneous relapse. Primary and secondary cutaneous FL share many clinical and phenotypic features, but primary cases may have some distinctive morphologic features, more frequently lack bcl-2 protein, and often lack the t(14;18) translocation. These findings suggest that primary cutaneous FL are distinctive and often but not always have a pathogenesis different from most of nodal and secondary cutaneous FL.

[1]  P. Batstone,et al.  Extranodal follicular lymphoma: a clinicopathological and genetic analysis of 15 cases arising at non‐cutaneous extranodal sites , 2004, Histopathology.

[2]  H. Kerl,et al.  Differential Diagnosis of Cutaneous Infiltrates of B Lymphocytes with Follicular Growth Pattern , 2004, The American Journal of dermatopathology.

[3]  G. Fleuren,et al.  Bcl‐2, Bcl‐6 and CD10 expression in cutaneous B‐cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance , 2003, The British journal of dermatology.

[4]  P. McKay,et al.  Primary Cutaneous Diffuse Large B-cell Lymphoma: Prognostic Significance of Clinicopathological Subtypes , 2003, The American journal of surgical pathology.

[5]  A. Nicholson,et al.  Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. , 2003, Blood.

[6]  G. Wood,et al.  Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. , 2003, Human pathology.

[7]  G. Ott,et al.  T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. , 2003, Blood.

[8]  U. Surti,et al.  Primary and Secondary Cutaneous Diffuse Large B-Cell Lymphomas: A Multiparameter Analysis of 25 Cases Including Fluorescence In Situ Hybridization for t(14;18) Translocation , 2003, The American journal of surgical pathology.

[9]  L. Staudt,et al.  The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. , 2003, Cancer cell.

[10]  W. Chan,et al.  The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade. , 2002, American journal of clinical pathology.

[11]  P. McKay,et al.  Primary Cutaneous Follicular Lymphoma A Clinicopathologic and Molecular Study of 16 Cases in Support of a Distinct Entity , 2002 .

[12]  A. Rosenwald,et al.  Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. , 2002, Blood.

[13]  R. Gascoyne,et al.  Primary cutaneous diffuse large B-cell lymphoma: a clinicopathologic study of 15 cases. , 2002, American journal of clinical pathology.

[14]  R. Gascoyne,et al.  Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  H. Kerl,et al.  Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. , 2002, Blood.

[16]  S. Whittaker,et al.  Absence of the t(14; 18) chromosomal translocation in primary cutaneous B‐cell lymphoma: reply from authors , 2002, The British journal of dermatology.

[17]  J. Taubenberger,et al.  Cutaneous Follicle Center Lymphoma: A Clinicopathologic Study of 19 Cases , 2001, Modern Pathology.

[18]  M. Piris,et al.  Cutaneous Follicular B-Cell Lymphoma: Description of a Series of 18 Cases , 2001, The American journal of surgical pathology.

[19]  N. Harris,et al.  Cutaneous B-Cell Lymphomas of Follicular and Marginal Zone Types: Use of Bcl-6, CD10, Bcl-2, and CD21 in Differential Diagnosis and Classification , 2001, The American journal of surgical pathology.

[20]  K. Franssila,et al.  Causes and Consequences of BCL2 Overexpression in Diffuse Large B-Cell Lymphoma , 2001, Leukemia & lymphoma.

[21]  S. Swerdlow,et al.  Immunophenotypic and Genotypic Markers of Follicular Center Cell Neoplasia in Diffuse Large B-Cell Lymphomas , 2000, Modern Pathology.

[22]  H. Kerl,et al.  Primary cutaneous follicle center cell lymphoma with follicular growth pattern. , 2000, Blood.

[23]  R. Tubbs,et al.  Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization. , 2000, The American journal of surgical pathology.

[24]  S. Pals,et al.  Cell adhesion receptors in lymphoma dissemination. , 2000, Blood.

[25]  S. Swerdlow,et al.  Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel. , 2000, Applied immunohistochemistry & molecular morphology : AIMM.

[26]  C. Meijer,et al.  EORTC classification for primary cutaneous lymphomas: the best guide to good clinical management. European Organization for Research and Treatment of Cancer. , 1999, The American Journal of dermatopathology.

[27]  D. Arber,et al.  Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[28]  K. Franssila,et al.  BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. , 1997, Blood.

[29]  R. Willemze,et al.  Relation between expression of adhesion molecules and clinical behavior in cutaneous follicle center cell lymphomas. , 1997, Journal of the American Academy of Dermatology.

[30]  H. Kerl,et al.  EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. , 1997, Blood.

[31]  E. Noordijk,et al.  Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  R. Gascoyne,et al.  Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma. , 1995, American journal of clinical pathology.

[33]  D. Slater MALT and SALT: the clue to cutaneous B‐cell lymphoproliferative disease , 1994, The British journal of dermatology.

[34]  P. Gaulard,et al.  BCL2 gene activation and protein expression in follicular lymphoma: a report on 64 cases. , 1993, Leukemia.

[35]  J. Rowley Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  B. Osborne,et al.  Follicular lymphoma mimicking progressive transformation of germinal centers. , 1987, American journal of clinical pathology.